Therapeutic Efficacy and Safety of Recombinant Botulinum Toxin Type A for Moderate to Severe Glabellar Lines: A Randomized, Controlled, Double-blind, Phase III Trial in Chinese Adults
YY001 demonstrated strong efficacy and a favorable safety profile than Botox®. Longer-term and multicenter studies are needed to assess durability, immunogenicity, and applicability across broader populations.
Authors
- Lai Wei (ORCID: https://orcid.org/0000-0003-1000-7559)
- D. Wu
- Lei Li (ORCID: https://orcid.org/0000-0001-8723-3461)
- Jian Sun (ORCID: https://orcid.org/0000-0003-0067-5967)
- Huiping Wang (ORCID: https://orcid.org/0000-0002-0385-4701)
- Jin Chen (ORCID: https://orcid.org/0000-0001-8352-3576)
- Sufan Wu
- Baoxi Wang
- Jianyun Lu
- Hongsen Bi
- ShengKang Luo
- J Yang
- Xiaoli Sun
- Nanze Yu
- Wu Yang
- Xiao Long
- Lina Tan
- Yan Wu
- Xiaoyun Sun
- Liming Wu
- Songmei Geng
Institutions
- Central South University (CN)
- Sun Yat-sen University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Sichuan University (CN)
- Peking Union Medical College Hospital (CN)
- Tianjin Medical University General Hospital (CN)
- West China Hospital of Sichuan University (CN)
- Nanfang Hospital (CN)
- Wuhan Union Hospital (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Peking University First Hospital (CN)
- Zhejiang Provincial People's Hospital (CN)
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
- Peking University Third Hospital (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
- Beijing Tsinghua Chang Gung Hospital (CN)
- Guangdong Provincial People's Hospital (CN)
- Third Xiangya Hospital (CN)
- Union Hospital (CN)
- Chongqing Medical and Pharmaceutical College (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Aesthetic Surgery Journal
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1093/asj/sjag042
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00